The Ministry of Health and Family Welfare has released India’s first-ever guidance document on diabetes mellitus in children at the recently concluded National Summit on Best Practices in Public Healthcare Service Delivery.
This landmark document establishes, for the first time, a structured and standardized national framework for the screening, diagnosis, treatment, and long-term management of childhood diabetes.
With this initiative, India joins a select group of countries that have successfully integrated childhood diabetes care into their public health systems.
The guidance aims to ensure universal screening of children from birth to 18 years, enabling early detection through community- and school-based platforms. According to a government statement, suspected cases will undergo immediate blood glucose testing, followed by timely referral to district-level health facilities for confirmatory diagnosis and treatment.
A key highlight of the framework is the provision of a comprehensive, free-of-cost care package at public health facilities. This includes screening and diagnostic services, lifelong insulin therapy, essential monitoring devices such as glucometers and test strips, and regular follow-up care. The approach is designed to reduce the financial burden on families while ensuring uninterrupted treatment for children diagnosed with diabetes.
The document also introduces an integrated continuum of care, seamlessly linking community-level screening with district hospital-based management and advanced care at medical colleges. This coordinated approach ensures that no child is lost within the system and that care continues consistently from early detection to long-term management.
To strengthen early identification, the initiative promotes the “4Ts” awareness framework — Toilet, Thirsty, Tired, and Thinner — helping parents, teachers, and caregivers recognize the early warning signs of Type 1 diabetes.
Beyond clinical care, the document emphasizes family and caregiver empowerment. It provides structured training on insulin administration, blood glucose monitoring, emergency response, and daily disease management. It also outlines evidence-based treatment protocols, regular monitoring schedules, and strategies to prevent complications.
The initiative is expected to yield significant public health benefits, including reduced mortality through early detection, prevention of complications, and improved quality of life for affected children. In the long term, it is also likely to lower healthcare costs and strengthen the health system’s capacity to manage non-communicable diseases among children.
Overall, the release of this guidance document underscores the government’s commitment to delivering accessible, affordable, equitable, and quality healthcare for all children, with a strong focus on early intervention, continuity of care, and better health outcomes.